Latest filing published 05 Sept 2023 for Moberg Pharma AB (publ), €6,493.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Nikolaj Arrild Sørensen: trading record in brief
Nikolaj Arrild Sørensen discloses dealings in Moberg Pharma AB (publ) to Finansinspektionen. Between 27 May 2022 and 30 August 2023, the trades on record add up to 3 filings.
Every open-market trade on record is a purchase: 2 purchases worth €18k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2023: 1 purchase and no sales on the market.
On 5 September 2023 came the latest disclosure, an open-market purchase for €6,493 in Moberg Pharma AB (publ). Filings reach the Finansinspektionen feed a median of 4 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Nikolaj Arrild Sørensen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,377 shares@ SEK 5.7531.2% of flowBTU (betald tecknad unit)ISIN SE0020678969FI:csv-db54f9c3e9d3efbf22a2Canonical exit: 28 Nov 2023 (T+90)
- 54,000 shares@ SEK 2.3082.9% of flowBTA (betald tecknad aktie)ISIN SE0017859085FI:csv-5319213a78a8a9381b19Canonical exit: 30 Aug 2022 (T+90)
- 11,250 shares@ SEK 2.3017.1% of flowBTA (betald tecknad aktie)ISIN SE0017859085FI:csv-85c402192e20bd9aa54b
3 of 3 declarations